[1]
Eandi, M. and Ferrero, L. 2003. Mesalazina: profilo farmacologico, terapeutico e farmacoeconomico. Farmeconomia. Health economics and therapeutic pathways. 4, 4 (Dec. 2003), 201–216. DOI:https://doi.org/10.7175/fe.v4i4.780.